Recital 3, Regulation (EU) 2024/1331

In forcesince 28 Feb 2024

IMDPAM is used to produce 3,4-Methylenedioxyphenylpropan-2-one, which, in turn, is a precursor of 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ‘ecstasy’.